CeriBell (CBLL) Stock Analysis

What CeriBell does

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.

Key metrics

ETFs linked to CBLL

Broad-market and Healthcare sector ETFs an investor holding CeriBell is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how CBLL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for CeriBell?

CeriBell trades under the ticker CBLL on NASDAQ.

Which exchange is CBLL listed on?

CBLL is listed on NASDAQ.

What sector does CeriBell operate in?

CeriBell is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze CBLL in a portfolio?

PortView shows CBLL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.